Timothy Carll to Middle Aged
This is a "connection" page, showing publications Timothy Carll has written about Middle Aged.
Connection Strength
0.064
-
Transfusion management and hemoglobin-based oxygen carrier treatment in a patient with anti-Rh17 antibody. Transfusion. 2024 Jun; 64(6):1161-1166.
Score: 0.015
-
Refractory vaccine-induced immune thrombotic thrombocytopenia (VITT) managed with delayed therapeutic plasma exchange (TPE). J Clin Apher. 2022 Feb; 37(1):117-121.
Score: 0.013
-
Pembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in Melanoma. J Clin Oncol. 2021 08 20; 39(24):2647-2655.
Score: 0.012
-
Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I Trial. Clin Cancer Res. 2020 12 15; 26(24):6437-6444.
Score: 0.012
-
Randomized Phase II Trial and Tumor Mutational Spectrum Analysis from Cabozantinib versus Chemotherapy in Metastatic Uveal Melanoma (Alliance A091201). Clin Cancer Res. 2020 02 15; 26(4):804-811.
Score: 0.011